TY  - CHAP
M1  - Book, Section
TI  - Esophageal Cancer
A1  - Ursem, Carling
A1  - McQuaid, Kenneth R.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Key  Clinical  Updates  in  Esophageal  CancerFor  patients  who  complete  neoadjuvant  chemoradiation  and  undergo  a  complete  resection  but  are  found  to  have  residual  cancer  in  the  resection  specimen,  a  year  of  adjuvant  immunotherapy  with  nivolumab  is  recommended.Ahmed  O  et  al.  Clin  Gastroenterol  Hepatol.  [PMID:  33813072]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/06
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193162277
ER  -